NFKB1 and neoplasm: Zhu L, et al. emphasize immune cell infiltration, noting differential expression of seven immune cell types (e.g., Th17 cells) in high- versus low-risk groups, with SP110 upregulation potentially enhancing anti-tumor immunity (via NF-κB or Th17-mediated responses).